Fluid, electrolyte and acid-base disorders associated with antibiotic therapy

被引:78
作者
Zietse, R. [1 ]
Zoutendijk, R. [1 ]
Hoorn, E. J. [1 ]
机构
[1] Erasmus MC, Dept Nephrol, NL-3000 CA Rotterdam, Netherlands
关键词
RENAL TUBULAR-ACIDOSIS; AMPHOTERICIN-B; SODIUM TRANSPORTERS; LACTIC-ACIDOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE; AQUAPORIN-2; EXPRESSION; DIABETES-INSIPIDUS; CELL-DEATH; GENTAMICIN; NEPHROTOXICITY;
D O I
10.1038/nrneph.2009.17
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Antibiotics are among the most frequently prescribed drugs in medicine. Their use, however, is often limited by associated renal toxic effects. The most common manifestation of these toxic effects is decreased glomerular filtration rate. However, they can also occur while renal function remains near to normal. This review focuses on antibiotic-associated fluid, electrolyte and acid-base disorders that do not greatly reduce glomerular filtration. renal tubules can be affected by antibiotics at various locations. in the proximal tubule, toxic effects of tetracyclines and aminoglycosides can result in complete proximal tubular dysfunction, also known as Fanconi syndrome. Aminoglycosides (and capreomycin) can also affect the loop of Henle and lead to a Bartter-like syndrome. in the collecting ducts, antibiotics can cause a diverse range of disorders, including hyponatremia, hypokalemia, hyperkalemia, renal tubular acidosis, and nephrogenic diabetes insipidus. Causative antibiotics include trimethoprim, amphotericin B, penicillins, ciprofloxacin, demeclocycline and various antitubercular agents. Here, we describe the mechanisms that disrupt renal tubular function. integrated with the physiology of each successive nephron segment, we discuss the receptors, transporters, channels or pores that are affected by antibiotics. This insight should pave the way for pathophysiology-directed treatment of these disorders.
引用
收藏
页码:193 / 202
页数:10
相关论文
共 103 条
[1]  
Adler Dan, 2004, Eur J Intern Med, V15, P463, DOI 10.1016/j.ejim.2004.08.003
[2]   TRIMETHOPRIM-SULFAMETHOXAZOLE AND HYPONATREMIA [J].
AHN, YH ;
GOLDMAN, JM .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :161-162
[3]   Molecular Determinants of Magnesium Homeostasis: Insights from Human Disease [J].
Alexander, R. Todd ;
Hoenderop, Joost G. ;
Bindels, Rene J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (08) :1451-1458
[4]   Aminoglycoside-induced reversible tubular dysfunction [J].
Alexandridis, G ;
Liberopoulos, E ;
Elisaf, M .
PHARMACOLOGY, 2003, 67 (03) :118-120
[5]   Human organic anion transporters mediate the transport of tetracycline [J].
Babu, E ;
Takeda, M ;
Narikawa, S ;
Kobayashi, Y ;
Yamamoto, T ;
Cha, SH ;
Sekine, T ;
Sakthisekaran, D ;
Endou, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 (01) :69-76
[6]   Time dependent effects of gentamicin on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in rat kidney tissues [J].
Banday, Anees A. ;
Farooq, Neelam ;
Priyarnvada, Shublia ;
Yusufi, Ahad N. K. ;
Khan, Farah .
LIFE SCIENCES, 2008, 82 (9-10) :450-459
[7]   VASOPRESSIN-RESISTANT NEPHROGENIC DIABETES-INSIPIDUS - RESULT OF AMPHOTERICIN-B THERAPY [J].
BARBOUR, GL ;
STRAUB, KD ;
ONEAL, BL ;
LEATHERMAN, JW .
ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (01) :86-88
[8]  
Barcia JP, 1998, PHARMACOTHERAPY, V18, P874
[9]   SUBCELLULAR-DISTRIBUTION OF GENTAMICIN IN PROXIMAL TUBULAR CELLS, DETERMINED BY IMMUNOGOLD LABELING [J].
BEAUCHAMP, D ;
GOURDE, P ;
BERGERON, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2173-2179
[10]   MICROSOMAL PROTEIN-SYNTHESIS INHIBITION - AN EARLY MANIFESTATION OF GENTAMICIN-NEPHROTOXICITY [J].
BENNETT, WM ;
MELARIKER, LM ;
HOUGHTON, DC ;
GILBERT, DN ;
BUSS, WC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (02) :F265-F269